Christopher Ogilvy, MD

Director, Endovascular and Operative Neurovascular Surgery, Professor, Harvard Medical School
BIDMC Brain Aneurysm Institute, Harvard Medical School
Boston, Massachusetts, United States

Christopher S. Ogilvy, M.D.





Christopher Ogilvy, M.D. is the Director, Endovascular and Operative Neurovascular Surgery BIDMC Brain Aneurysm Institute and Professor of Neurosurgery, Harvard Medical School. Dr. Ogilvy is known nationally and internationally for his work in neurointerventional and operative procedures, and has been a moving force in the field of neurovascular disease for the last twenty years.

Dr. Ogilvy’s research and academic endeavors are in the areas of neurovascular disease including intracranial aneurysms, arteriovenous malformations and atherosclerotic disease. Much of his work has been focused on studying outcomes of operative and endovascular procedures. In the laboratory, efforts have been focused on studying cerebral ischemia in the setting of neurovascular procedures, with a recent focus on the biology of intracranial aneurysms and the use of tissue engineering techniques to treat saccular intracranial aneurysms. He has pioneered several techniques in surgical procedures and is pursuing avenues of research in clinical treatment of patients with intracranial vascular problems using endovascular techniques.

Dr. Ogilvy is past President of the New England Neurosurgical Society and has served on numerous national neurosurgical committees. He is the Medical Director of the Brain Aneurysm Foundation, a national organization to help patients and families with brain aneurysms and to fund clinical and basic research. He is an Associate Editor for the journal Neurosurgery. He has published extensively, with over 400 original manuscripts and over 100 book chapters in the area of neurovascular surgery.

Presentation(s):

• M. Gazi Yasargil Lecture

  Sunday, April 23, 2023
  1:35pm – 2:05pm PST

  Disclosure(s): No financial relationships to disclose

• (SSC) Discussion (Q&A)

  Sunday, April 23, 2023
  2:06pm – 2:10pm PST

  Disclosure(s): No financial relationships to disclose